mmHg and -4-6 (13.8) respectively (p<O0OS). This benefit was still observed after two years of follow up (- (17.4) numHg v -7 5 (14.2) mmHg (p<0.05)).
No difference was observed in DBP. The percentage of treated subjects did not differ between groups. At one year, AAC was larger in the intervention group (-28 (5.2) Uid) than in the control group (-1-6 (3.4) (p<0-1)). AGGT A protective effect of alcohol consumptionparticularly wine -on cardiovascular disease has been reported in many studies.' However, this effect was observed for moderate daily intakes. In contrast, high consumption is associated with a high incidence of coronary heart diseases, cerebral haemorrhage, and increased total mortality.24 High blood pressure (BP) partly accounts for these results. Alcohol consumption has been shown to be a risk factor for high Bp,5-8 an effect which is reversible.9-l '3 In addition, BP control and compliance with antihypertensive treatment were shown to be low in this group of heavy alcohol consumers.8 14'5 In France, mortality from cardiovascular diseases on one hand and alcohol related diseases on the other hand, is highly correlated. For instance, cerebrovascular and alcohol related mortality rates were 767 and 2160/million inhabitants aged 35 to 64 years among rural workers in Brittany compared with values of 46 and 98 respectively among executives in Champagne. '6 These data suggest that cardiovascular health improvement might be expected from strategies aimed at groups in the population characterised by high alcohol intakes. In a recent review, Ockene noted that despite their unusually high incidence of poor health behaviours, research examining treatment options in populations of alcohol abusers has not been done. '7 There is a well known relationship between alcohol consumption and BP. -13 Whether reducing alcohol intake on a long term basis is associated with a decrease in BP is not documented. We therefore undertook a study to an intervention and a control group. The units of randomisation were the worksite physicians. Each one was in charge of one or several companies. They were allocated to either group after they had given consent and both the managers and the personnel of the companies to be included had agreed. In France, an annual medical examination by the worksite physician is mandatory. At this visit, each physician included any subject who met the criteria for the study and gathered the data. The main outcome measure was the difference in BP between the base line at inclusion and after one year of follow up (ABP). This difference after two years of folllow up was a secondary end point of the study. The other secondary criteria were the difference between initial and final r glutamyltransferase (GGT) activities (AGGT), alcohol consumption (AAC) as stated by the subject, body mass index (ABMI), the percentage of subjects currently taking antihypertensive treatment, and the frequency and length of work absenteeism for illness or accidents.
INCLUSION OF WORKSITE PHYSICIANS
These were recruited on a voluntary basis through professional networks. If they agreed to participate, they had to explain the study to the committees of the companies to be included. These committees (CHSCT: Comites d'Hygiene, de S&curite et des Conditions de Travail) are composed of the representatives of the personnel and of the managerial staff. They deal with safety of working conditions, and health problems. Worksite physicians were randomised only after securing the agreement of these committees. In each group, the physicians included every eligible subject in the study. After randomisation, both groups of physicians received a training session on BP measurement. A written protocol was given to each physician describing the criteria for inclusion and collection of data in both groups, as well as the intervention in the intervention group. As far as BP was concerned, in both groups, a letter was sent by the worksite physician to the subject's doctor, reporting the BP measurement results. If necessary, subjects with no general practitioner were advised to make an appointment with a doctor or at the hospital.
INCLUSION OF THE INDIVIDUALS
To be eligible, a subject had to fulfil two conditions -to be hypertensive and an excessive drinker. At the first screening visit, subjects were temporarily included if their BP was over 140/90 mmHg (mean of the two measurements at each visit), whether or not they were currently on antihypertensive treatment. Their GGT value was requested for a second meeting. At the second visit, one month later, these subjects were definitely included in the study if (1) 
INTERVENTION
The intervention was directed at both the worksite physicians and the patients. In the intervention group, training sessions for the physicians were organised before the study began and, one, three and six months afterwards. Specialists in alcohol related diseases, a consultant in legal and social aspects of alcohol at the workplace, and a psychiatrist also attended these sessions. Sharing of experiences between the physicians was an important part of these meetings. As far as the subjects were concerned, they were invited to visit the worksite physician after one, three, six, and 18 months, and on each occasion to bring the result of their GGT determination. The frequency and dates of these visits were strictly standardised and monitored, as was the performance of a GGT test. The relationship between the physician and the subject was standardised as much as possible. The subject was encouraged to find for himself the level of alcohol consumption which would lower his GGT activity to within the normal range. The goal of the intervention was not to stop alcohol intake in all subjects but to reach a moderate level of consumption, since most of these drinkers were not expected to be alcohol dependent. With these subjects, changing from excessive social drinking to controlled consumption is believed to be possible.2' The efficacy of this model was suggested by a study in Sweden.22 No emphasis was placed on BP, the measurement of which was not part of the protocol. Physicians in both groups were asked to measure BP at only three encounters -at inclusion and at one and two years.
Physicians in the control group were requested to continue with their current procedures, including any activity or campaign dealing with cardiovascular diseases or alcohol. ment, due to the reduction in alcohol consumption. Conversely, in case of a larger reduction in the intervention group, the percentage of treated hypertensives was to be analysed in order to make a distinction between lower BP levels resulting from decreased alcohol consumption and those due to increased antihypertensive therapy.
Results

POPULATION
Nineteen occupational physicians were recruited. Six of them participated in the feasibility study: two had no subjects who met the study criteria and one had to stop for personal health reasons. Among the remaining 13 physicians, one did not have any subjects who met the study criteria and one had to stop before the beginning of the study. Fourteen randomised doctors therefore participated in the full study. A total of 15 301 subjects were examined during the annual examination. Of these, 460 met the BP criteria for eligibility at the first visit. Eventually, 129 subjects met both the BP and excessive drinking criteria and were thus included in the study. The percentages of eligible subjects did not differ significantly between the two groups (3 3% and 3 0%), nor did the proportions of subjects included (0-8% and 0 7%). Most subjects were men (95%) and their mean (SD) age was 43 (7) (6 7) mmHg, n= 9) (NS).
There was also a larger ASBP in the intervention group (-11-0 (18&7)mmHg, n= 13) than in the control group (+1-8 (12-4) mmHg, n= 19) in subjects who had no GGT result at inclusion. Twenty one per cent of the patients in the intervention group and 18% in the control group were currently taking antihypertensive treatment at the beginning of the study (NS). In both groups, two patients stopped antihypertensive treatment and six began it during the study. The pattern of antihypertensive medications did not change significantly during the study.
BP after two years Across the entire sample of physicians, ASBP was -14-0 (16-6) mmHg in the intervention group and -7 4 (14-1) mmHg in the control group (p<0 05) (figure). When the five physicians who had included fewer than five patients were excluded, the decrease in SBP levels remained significantly larger in the intervention group than the control group (table 3) . In addition, the heart rate and changes between study inclusion and the final examination did not differ between the two groups. Furthermore, the weak correlation between the reduction in BP and alcohol consumption suggests that the latter might be at least partly responsible for the reduction in BP. It thus seems unlikely that the white coat effect is entirely responsible for the result observed. The consistency of the results after two years follow up is a last argument for the causal effect of a reduction in alcohol consumption. It is, however, surprising that the only reduction observed was a reduction in BP, whereas only a tendency for a decrease in alcohol intake and no effect from GGT were observed. One could hypothesise that the effect on BP is independent of alcohol consumption. An increase in the number of treated subjects can be ruled out. However, therapeutic control might be improved through increased compliance with drug treatment. From our data, the stated compliance did not change throughout the study. This is, in fact, a poor measure of the true compliance. If this mechanism is involved, which was one of our expectations, it would only be part of the effect since BP decreased in both treated and untreated patients in the intervention group compared with the control group.
The stated alcohol consumption was slightly reduced during the study in the intervention group. This measure has been shown to be impaired by great In short term trials,9'13 as well as in studies dealing primarily with alcohol consumption,33 a decrease in BP was observed. This physiological measure might thus be a useful indicator of changes in alcohol consumption, easy to measure and independant ofthe observer, when evaluating the effectiveness of strategies to reduce drinking.
The predominant effect on SBP and the lack of effect on diastolic BP agrees with previous reports emphasising a closer relationship,7 sometimes exclusive,'0 of alcohol intake with SBP. A closer correlation between alcohol and GGT was found in both groups at the end of the study compared with the beginning. It is worth observing that this improvement was much larger in the intervention than the control group, suggesting that an effect of the intervention was to induce more accurate measurement of alcohol consumption by the drinkers, or to improve the quality of the relationship between the doctor and the patient, or both. Although the same tendency was observed whatever the subgroup of physicians considered, the largest effect in reducing BP was obtained by the physicians who included between five and 10 subjects. Both results emphasise the importance and the effectiveness of the doctor-patient relationship in such a strategy.
The effectiveness and cost effectiveness of worksite intervention programmes has been shown. 34 Our study extends the effectiveness of this approach when "hard to reach" populations -heavy drinkers in our study -are the target of the intervention. As far as the alcohol problem is concerned, our results agree with those of Wallace with general practitioners. 32 In this study, a simple intervention proved to be successful on stated alcohol consumption, BP, and to a lesser extent GGT. Another study reported an effect on stated alcohol consumption,35 but the subjects lost to follow up were numerous (35%). Two other studies failed to reduce alcohol consumption in heavy drinkers.3637 The subjects we included were heavier drinkers than in the other studies, in none of which were GGT activities over 52 UI/l. The mean was over 140 IU/l in our population. Despite the enormous difficulties to face in this field, prevention of alcoholism through a reduction in the consumption of heavy drinkers before the occurrence ofdependency, seems to be a promising research direction.
Conclusion
An intervention aimed at the hypertensive excessive drinkers in a working population was found to be effective in reducing SBP on the long term. The mechanisms -reduction in alcohol consumption and improved antihypertensive drug compliance -cannot be ascertained in this pragmatic study. However, the small number of treated antihypertensive in this study, as well as the results of other trials,9 13 suggest that a reduction in alcohol consumption accounts partly for this result. From a public health point of view, it seems feasible to reduce the excess cardiovascular risk among a "hard to reach" population, with a strategy specifically designed for this high risk group. The difference obtained with this strategy is comparable to that obtained through drug treatment in randomised drug trials.38
